Cronos Group Inc

Company Profile

Cronos Group Inc had its IPO on 2016-07-12 under the ticker symbol CRON.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Cronos Group Inc has a staff strength of 447 employees.

Stock update

Shares of Cronos Group Inc opened at $2.39 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.22 - $2.46, and closed at $2.25.

This is a -6.25% slip from the previous day's closing price.

A total volume of 6,317,778 shares were traded at the close of the day’s session.

In the last one week, shares of Cronos Group Inc have increased by +14.21%.

Cronos Group Inc's Key Ratios

Cronos Group Inc has a market cap of $652.04 million, indicating a price to book ratio of 0.8969 and a price to sales ratio of 11.218.

In the last 12-months Cronos Group Inc’s revenue was $87.02 million with a gross profit of $11.97 million and an EBITDA of $-97537000. The EBITDA ratio measures Cronos Group Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cronos Group Inc’s operating margin was -124.73% while its return on assets stood at -5.36% with a return of equity of -12.69%.

In Q1, Cronos Group Inc’s quarterly earnings growth was a positive 14.4% while revenue growth was a negative 19.5%.

Cronos Group Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.41 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cronos Group Inc’s profitability.

Cronos Group Inc stock is trading at a EV to sales ratio of 1.8557 and a EV to EBITDA ratio of -0.5699. Its price to sales ratio in the trailing 12-months stood at 11.218.

Cronos Group Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.16 billion

Total Liabilities

$29.13 million

Operating Cash Flow

$-303812000.00

Capital Expenditure

$804000

Dividend Payout Ratio

0%

Cronos Group Inc ended 2024 with $1.16 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.16 billion while shareholder equity stood at $1.13 billion.

Cronos Group Inc ended 2024 with $378000.00 in deferred long-term liabilities, $29.13 million in other current liabilities, 612235000.00 in common stock, $471.51 million in retained earnings and $1.04 million in goodwill. Its cash balance stood at $413.67 million and cash and short-term investments were $836.43 million. The company’s total short-term debt was $1,236,000 while long-term debt stood at $0.

Cronos Group Inc’s total current assets stands at $916.14 million while long-term investments were $153.20 million and short-term investments were $422.76 million. Its net receivables were $27.47 million compared to accounts payable of $12.84 million and inventory worth $44.27 million.

In 2024, Cronos Group Inc's operating cash flow was $-303812000.00 while its capital expenditure stood at $804000.

Comparatively, Cronos Group Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.25

52-Week High

$3.616

52-Week Low

$1.66

Analyst Target Price

$3.74

Cronos Group Inc stock is currently trading at $2.25 per share. It touched a 52-week high of $3.616 and a 52-week low of $3.616. Analysts tracking the stock have a 12-month average target price of $3.74.

Its 50-day moving average was $1.89 and 200-day moving average was $2.11 The short ratio stood at 6.89 indicating a short percent outstanding of 0%.

Around 4684.6% of the company’s stock are held by insiders while 1352.2% are held by institutions.